Ergothioneine & Inflammation
Explore mushroom research and guides on ergothioneine & inflammation.
Ergothioneine and Chronic Inflammatory Conditions
Low ergothioneine tracks with rheumatoid arthritis, psoriasis, IBD, and 21% lower cardiovascular survival. What the chronic inflammation research shows.
Ergothioneine and COVID-19: Inflammation Research
A 2020 paper proposed five ways ergothioneine could reduce COVID-19 severity. Here is the evidence and what it cannot claim about this mushroom compound.
Ergothioneine Anti-Inflammatory: The Research Evidence
Ergothioneine blocks NF-κB, MAPK, and JAK/STAT3: three inflammation switches. Here is what the research shows, including the only human clinical trial.
Ergothioneine as a Biomarker: What Low Levels Predict
Low ergothioneine is an inflammatory biomarker linked to 21% higher cardiovascular mortality, cognitive decline, and arthritis. Here's what the data actually shows.
OCTN1: Ergothioneine Accumulation at Inflammation Sites
OCTN1 is the only transporter for ergothioneine. It concentrates the compound in immune cells and redirects it to inflamed tissue during active inflammation.